Anika to arm obvious infraction lawsuit to go to MONOVISC produce
Anika Therapeutics, Inc. (Nasdaq: ANIK), a chief in products fitting for concatenation safe keeping, healing and nick, based on hyaluronic acid ("HA") technology, announced today that they had been served with a complaint alleging apparent breaking with civility to the MONOVISC product by Genzyme Corporation. This kick was filed in the United States District Court for the Neighbourhood of Massachusetts on July 7, 2010. The company intends to vigorously support the lawsuit and the MONOVISC issue franchise.
“Management’s Talk and Judgement of Economic Working order and Results of Operations”
SOURCE Anika Therapeutics, Inc.
Help-Medical.net finds at this phrases:
- merck frosst
- hoya insert intraocular lens
- how reliable is hiv agab test
- how reliable is hiv agab test
- laptop hf
- ranexa copyright
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
